Bordetella Hinzii Pneumonia and Bacteremia in a Patient With SARS-CoV-2 Infection

Michele Maison-Fomotar; Geetha Sivasubramanian

Disclosures

Emerging Infectious Diseases. 2021;27(11):2904-2907. 

In This Article

Abstract and Introduction

Abstract

Patients with severe acute respiratory syndrome coronavirus 2 infection may have bacterial co-infections, including pneumonia and bacteremia. Bordetella hinzii infections are rare, may be associated with exposure to poultry, and have been reported mostly among immunocompromised patients. We describe B. hinzii pneumonia and bacteremia in a severe acute respiratory syndrome coronavirus 2 patient.

Introduction

Since the December 2019 beginning of the coronavirus disease (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus (SARS-CoV-2), there have been >180 million cases and >3.9 million deaths worldwide.[1] Severe bacterial and fungal co-infections are a major concern with COVID-19 and increase disease mortality.[2]

The genus Bordetella comprises >10 known species of small, gram-negative coccobacilli, the most common of which is Bordetella pertussis.[3]Bordetella hinzii was first identified as a cause of respiratory infection in poultry and more rarely in rodents.[4] It was first reported as a human infection in a patient with HIV infection in 1994 as a cause of bacteremia[5] and has subsequently been identified as a cause of soft tissue infections, pneumonia, cholangitis, urinary tract infections, bacteremia, and endocarditis, most often in immunocompromised patients (;[4–15] Appendix references[16,17] https://wwwnc.cdc.gov/EID/article/27/11/21-1468-App1.pdf). We report a case of B. hinzii pneumonia and bacteremia in a patient with SARS-CoV-2 infection.

processing....